Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Clover Health Investments Corp shares valued at $722,000 were sold by Edwards Carladenise Armbrister on Mar 07 ’25. At $3.61 per share, Edwards Carladenise Armbrister sold 200,000 shares. The insider’s holdings dropped to 273,227 shares worth approximately $0.93 million following the completion of this transaction.
Also, Priest Brady Patrick sold 75,000 shares, netting a total of over 276,000 in proceeds. Following the sale of shares at $3.68 each, the insider now holds 2,418,151 shares.
Before that, Soares Karen had sold 52,500 shares from its account. In a trade valued at $199,500, the General Counsel & Secretary traded Clover Health Investments Corp shares for $3.80 each. Upon closing the transaction, the insider’s holdings decreased to 52,500 shares, worth approximately $4.42 million.
As published in their initiating research note from Craig Hallum on December 17, 2024, Clover Health Investments Corp [CLOV] has been a Buy and the price target has been revised to $6. Analysts at UBS started covering the stock with ‘”a Neutral”‘ outlook in a report released in early October. As of February 02, 2022, Cowen has increased its “an Underperform” rating to a “Market perform” for CLOV. Earlier on February 02, 2022, Canaccord Genuity initiated its rating. Their recommendation was “a Buy” for CLOV stock.
Analyzing CLOV Stock Performance
During the last five days, there has been a drop of approximately -1.73%. Over the course of the year, Clover Health Investments Corp shares have jumped approximately 7.94%. Shares of the company reached a 52-week high of $4.87 on 01/24/25 and a 52-week low of $2.80 on 04/07/25. A 50-day SMA is recorded $3.70, while a 200-day SMA reached $3.39.
Support And Resistance Levels for Clover Health Investments Corp (CLOV)
According to the 24-hour chart, there is a support level at 3.35, which, if violated, would cause prices to drop to 3.29. In the upper region, resistance lies at 3.43. The next price resistance is at 3.45. RSI (Relative Strength Index) is 42.00 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.09, which suggests the price will decrease in the coming days. Percent R is at 71.43%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
